In Ireland, in 2001, there were 185 new cases of cervical cancer diagnosed and almost 70 deaths. Yet cervical cancer is a preventable disease. Screening programmes, using cervical smears, have dramatically decreased the rates of cervical cancer in other countries. This is because there is a condition, which can be picked up on smears, called CIN, which if not treated, can lead to the development of cancer in a small number of women.
Cerviva is a multi-investigator collaboration encompassing researchers at 7 Irish academic institutions, 8 hospitals and 10 commercial diagnostic or biotechnology companies. The purpose of the consortium is to advance high quality peer-reviewed research programmes that provide the best possible information and guidance in the delivery of cervical screening services to Irish women.
Cerviva gratefully acknowledges the support of the Health Research Board in association with the Irish Cancer Society, the National Cancer Registry, Ireland, and the Dublin Molecular Medicine Centre.
 |
 |
 |
 |
